Markets:

Overview

News

Currencies

International

Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

9.200 -0.260 (-2.75%)

Streaming Delayed Price Updated: 3:42 PM EDT, Apr 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2 3 4 5 6 7 8 9

...

31 32 Next >

Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says ↗

February 27, 2025

Compass Pathways gains Stifel's Buy rating as its COMP360 psilocybin treatment advances in Phase 3 trials. Key depression study data expected in 2025-2026.

Via Benzinga

Compass Pathways Plc (CMPS) Q4 2024 Earnings Call Transcript ↗

February 27, 2025

CMPS earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

This Plumas Bancorp Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday ↗

February 27, 2025

Via Benzinga

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

February 27, 2025

From Compass Pathways plc

Via Business Wire

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

February 25, 2025

From Compass Pathways plc

Via Business Wire

Washington State Bills Seek to Legalize Psychedelics for Therapeutic Use

February 24, 2025

Via Investor Brand Network

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

February 18, 2025

From Compass Pathways plc

Via Business Wire

Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months ↗

February 14, 2025

Kennedy has previously advocated for decriminalizing psychedelics for therapeutic use, citing his son’s positive experience with the hallucinogenic brew ayahuasca.

Via Stocktwits

RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care. ↗

February 12, 2025

The Senate will vote Thursday on whether to put RFK Jr. in charge of health. It's unclear how he will impact biotech stocks.

Via Investor's Business Daily

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

February 05, 2025

From Compass Pathways plc

Via Business Wire

Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer

January 21, 2025

From Compass Pathways plc

Via Business Wire

Compass Pathways Announces Pricing of Underwritten Offering

January 10, 2025

From Compass Pathways plc

Via Business Wire

Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)

December 18, 2024

From Compass Pathways plc

Via Business Wire

Is Your Mind Ready to Consider Investing in Psychedelics Stocks? ↗

November 29, 2024

Don't jump in without doing some research first.

Via The Motley Fool

Compass Pathways to Participate in December Investor Conferences

November 25, 2024

From Compass Pathways plc

Via Business Wire

COMPASS Pathways: Institutional Pressure Amid $43M Market Cap Decline, What's Next For This Psychedelics Co? ↗

November 25, 2024

COMPASS Pathways faces $43M market cap loss, raising concerns among institutional investors holding 30% ownership.

Via Benzinga

Despegar.com, Zai Lab, Bloom Energy And Other Big Stocks Moving Higher On Friday ↗

November 15, 2024

Via Benzinga

Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS ↗

November 15, 2024

President-elect Donald Trump tapped widely known vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.

Via Investor's Business Daily

Topics Government

FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment ↗

November 14, 2024

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory hurdles.

Via Benzinga

AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care? ↗

November 13, 2024

AI and psychedelic medicine are merging, with research showing AI's role in drug discovery, trials, and personalized mental health care.

Via Benzinga

Topics Artificial Intelligence

Top 3 Health Care Stocks You'll Regret Missing In November ↗

November 05, 2024

Via Benzinga

Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript ↗

October 31, 2024

CMPS earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

Nasdaq Down 500 Points; Uber Shares Dip After Q3 Results ↗

October 31, 2024

Via Benzinga

As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash ↗

October 31, 2024

Compass Pathways delays key Phase 3 psilocybin trial readouts, triggering a 30% workforce reduction amid efforts to conserve cash and refocus.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 31, 2024

Via Benzinga

Crude Oil Gains 1%; Meta Shares Fall Following Q3 Results ↗

October 31, 2024

Via Benzinga

Estée Lauder, Robinhood, eBay And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

October 31, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 31, 2024

Via Benzinga

Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates

October 31, 2024

From Compass Pathways plc

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

31 32 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.